Friday 20th January 2017
|Text too small?|
Bapcor, the ASX-listed autoparts firm, lifted its interest in Hellaby Holdings to 78.4 percent from 71.4 percent, edging closer to a takeover of the diversified investor it wants to break up while retaining its automotive business.
Bapcor has said it plans to sell Hellaby's equipment, resources and footwear businesses, using the remaining automotive division as a foothold in the New Zealand market, where car sales have been hitting record levels over the last three years due to a rapid increase in population and fast growing economy.
Hellaby's independent directors this week said they supported the takeover, having previously argued that it undervalued the company, after Bapcor declared its $3.60-per-share offer unconditional. The offer closes on Feb. 7.
Representatives of the two companies met last week to discuss the takeover after Bapcor gained effective control of Hellaby by securing more than 50 percent of the shares. It said Hellaby's independent directors have now provided Bapcor with "sufficient comfort around the remaining offer conditions" and these have now been lifted.
Hellaby shares last traded at $3.58 and have gained 26 percent in the past 12 months. Bapcor shares last traded at A$5.61 on the ASX and have surged 40 percent in the past 12 months. The stock is rated a 'buy' based on the consensus of three analysts polled by Reuters.
No comments yet
Gold Report 23rd July 2018
MARKET CLOSE: NZ shares down on Trump threats, A2 and Pushpay drop while Kathmandu rises
NZ dollar gains as markets fret about political pressure on the Fed
Tougher NZX disclosure obligations get mixed response in listing rules review
The Warehouse cuts up to 140 jobs in restructure; shares unchanged
Trustpower supports intent of emissions target but calls for careful consideration of impacts
NZ govt to consider imposing mānuka honey export criteria on local market
July 23rd Morning Report
NZ dollar gains as Trump bemoans strong greenback, rising US rates
MARKET CLOSE: NZ shares up, led by Fisher & Paykel Healthcare, Ryman